Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on February 9th, 2023%
A new enterprise, spun-off from labs at Northwestern University, says it’s designing electrochemical processes and systems for nanoscale materials to help meet the climate crisis. . . . → Read More: Green Energy Chemical Company Starts-Up, Raises $15M
By Alan, on January 26th, 2023%
Three new venture funds are seeking to invest up to $6.3 billion in start-up companies with advances in life sciences, health care, energy, and information technologies. . . . → Read More: New Venture Funds to Back Life Science, Tech Start-Ups
By Alan, on January 10th, 2023%
A bioengineering team devised techniques for feasibly adding cancer-killing enzymes to engineered immune cells that in lab mice kill solid-tumor and blood cancer cells. . . . → Read More: Nanotech Enzyme Process Boosts T-Cell Cancer Therapies
By Alan, on December 29th, 2022%
Engineers and neuroscientists developed a circuit that in lab mice connects implanted lab-grown brain tissue to the brain’s cognitive center and responds to visual stimuli. . . . → Read More: Implanted Organoid Connects to Brain, Reacts to Visual Cues
By Alan, on December 12th, 2022%
An experiment is underway testing a bone repair biomaterial in lab mice under weightless conditions on the International Space Station. . . . → Read More: Bone Regeneration Experiment Begun on Space Station
By Alan, on December 7th, 2022%
A technology investment company is partnering with a Silicon Valley incubator program to support start-up businesses developing new types of semiconductors. . . . → Read More: Venture Investor to Back Semiconductor Start-Ups
By Alan, on November 30th, 2022%
A company creating extended-release delivery techniques for eye therapies is raising $11.9 million in its first venture funding round. . . . → Read More: Sustained-Released Eye Treatment Company Raises $11.9M
By Alan, on July 25th, 2022%
A developer of synthetic biology tools and components is acquiring a biological materials developer for its automation assets as the biotechnology industry consolidates. . . . → Read More: Ginkgo Acquires Biomaterials Maker as Industry Consolidates
By Alan, on June 29th, 2022%
A study is underway testing 3-D printed regenerative breast tissue models, derived from genetically engineered plant cells, implanted in pigs. . . . → Read More: Preclinical 3-D Printed Breast Tissue Implant Study Begins
By Alan, on June 2nd, 2022%
A patient in a clinical trial received an implant made of three-dimensional printed tissue to replace a deformed ear caused by microtia, a congenital condition. . . . → Read More: Trial Demonstrates 3-D Printed Ear Tissue Implant
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|